Bristol Myers Squibb

Healthcare

Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot

Photo via imageBROKER/Rupert Oberh�user/Newscom

A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.

2 min read

Photo via Image courtesy of Genmab, All rights reserved. © 2024 Genmab A/S

Healthcare

Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus

BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”

2 min read
Photo via Mu Yu / Xinhua News Agency/Newscom

Healthcare

China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington

China’s pharmaceutical sector, a minor player just years ago, has revved up into a global juggernaut faster than a Fuxing high speed train.

2 min read
Photo via Richard B. Levine/Newscom

Healthcare

Pfizer Pops Despite Looming Pharma Tariffs

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US patients.

2 min read

Healthcare

Bristol Myers Paying BioNTech Up to $11.1B in Cancer Drug Team-up

Photo by Victor Golmer via iStock

At the heart of the biotech deal is a relatively new drug technology called PD-1/VEGF bispecific antibodies.

2 min read

(Photo credit: A 4/Flickr)

Healthcare

Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.